-
Journal article: A realist systematic review of evidence from low- and middle-income countries of interventions to improve immunization data use
The use of routine immunization data by health care professionals in low- and middle-income countries remains an underutilized resource in decision-making. Despite the significant resources invested in developing national health information systems, systematic reviews of the effectiveness of data use interventions are lacking. Applying a realist...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal. -
COVID-19 Vaccine Label: User Evaluation
Vaccine vial labels and packaging provide important information for healthcare workers, giving them confidence in how to administer a vaccine, and that it is safe and has maintained its potency. PATH’s Living Labs Initiative partnered with the World Health Organization and Coalition for Epidemic Preparedness Innovations (CEPI) to get healthcare worker feedback on the proposed universal draft models for COVID-19 vaccine vials and packaging. These labels are proposed to unify the labeling requirements for COVID-19 vaccines that will be supplied through the Access to COVID-19 Tools (Act) Accelerator.
Using human-centered design approaches, the Living Labs team gathered rapid insights on the proposed labels. These finding are being used to inform healthcare worker training on COVID-19 vaccine delivery and use, and to inform updates to label designs for future batches of vaccines produced by manufacturers. The Living Labs team leveraged existing relationships with immunization service providers in Zambia and Kenya to conduct this research study.
This page provides a list of key documents from PATH’s Living Labs Initiative to gather healthcare worker feedback on the proposed universal draft models for COVID-19 vaccine vials and packaging. It is organised into the following sections:
Process followed and results obtained
PATH Living Labs Initiative documents
Process and results
Starting in December 2020, healthcare workers used an online survey to provide feedback on a sample label. Then, in January 2021 they participated in focus groups to discuss the prototype COVID-19 vaccine cartons and vials. Working through various immunization and supply scenarios, they analyzed the packaging to identify the label information and training they would need for proper storage, handling, and dosing. These human-centered design workshops included working together to draw their ideal vaccine labels that included all desired features and information.
Many in the focus groups expressed that a clear, effective label should contain dosing information, handling instructions, a batch number, vaccine vial monitors to detect heat exposure, and an expiration date. Participants also expressed that it should be distinct as many vaccine vials look the same and that can cause confusion.
Some said a barcode would be useful to authenticate the vaccine, and that a URL for the product website would be useful to access more information if needed. However, many of their facilities did not have software to scan barcodes or internet connectivity to get online.
Additional insights and results can be accessed in the evaluation report linked in the table below.
These results have been shared with the ministries of health in Kenya and Zambia to help inform COVID-19 vaccine roll out plans and with the global immunization community to support better understanding of health care worker priority features for vaccine labels. Global discussions around COVID-19 vaccine label standardization are still ongoing and compete with other pressing COVID-19 priorities.
PATH Living Labs Initiative documents
{khub-list,reference,PATH-LLI,title ASC, 50}
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal. -
Hi everyone,
We are looking forward to PATH's webinar on Wednesday, May 19 (12-1pm CEST) covering: Findings from a healthcare worker evaluation of the COVID-19 vaccine label.
If you have not registered already please do so at this link: https://who.zoom.us/webinar/register/WN_fp8XO1xbTLyKEOyYBwJEWQ
Learn more about this work here: https://www.technet-21.org/en/topics/covid-19-labelling
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Description: PATH’s Living Labs Initiative used human-centered design methods to gather feedback on proposed labels for COVID-19 vaccine vials and cartons. Healthcare workers in Kenya and Zambia interacted with the labels and made recommendations for vaccine manufacturers for labels for future batches. This webinar will cover the human-centered design approaches used in this study and the feedback gathered on healthcare worker preferences for vaccine labelling. Additionally, PATH’s experts will discuss other insights gathered related to the support and training healthcare workers desire to feel confident in administering the COVID-19 vaccine.
When: Wednesday, 19 May 2021 (12-1pm CEST)
Speakers:
Oyugi Allela, Creative Designer, Living Labs Kenya
Steve Osumba, Creative Designer, Living Labs Kenya
Brenda Magula, Creative Designer, Living Labs Zambia
Casildah Lumamba, Creative Designer, Living Labs Zambia
Josephine Simwinga, Chief EPI Officer, Zambia Ministry of Health
R…
Lire la suiteDescription: PATH’s Living Labs Initiative used human-centered design methods to gather feedback on proposed labels for COVID-19 vaccine vials and cartons. Healthcare workers in Kenya and Zambia interacted with the labels and made recommendations for vaccine manufacturers for labels for future batches. This webinar will cover the human-centered design approaches used in this study and the feedback gathered on healthcare worker preferences for vaccine labelling. Additionally, PATH’s experts will discuss other insights gathered related to the support and training healthcare workers desire to feel confident in administering the COVID-19 vaccine.
When: Wednesday, 19 May 2021 (12-1pm CEST)
Speakers:
Oyugi Allela, Creative Designer, Living Labs Kenya
Steve Osumba, Creative Designer, Living Labs Kenya
Brenda Magula, Creative Designer, Living Labs Zambia
Casildah Lumamba, Creative Designer, Living Labs Zambia
Josephine Simwinga, Chief EPI Officer, Zambia Ministry of Health
Register here: https://who.zoom.us/webinar/register/WN_fp8XO1xbTLyKEOyYBwJEWQ
Learn more about this work: https://www.technet-21.org/en/topics/covid-19-labelling
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Meet the health workers who will co-create solutions for vaccine delivery
Frontline immunization workers play a critical role in improving vaccine access and equity. A new initiative aims to leverage their firsthand experience to co-create innovative delivery solutions.Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.To optimize COVID-19 vaccine rollout, listen to health workers
Health care workers in Kenya and Zambia are helping design vaccine preparedness and distribution plans.Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Living Labs Initiative Overview
PATH’s Living Labs Initiative accelerates the pace of health innovation by co-creating with users to rapidly design, test, and scale solutions to their long-standing challenges. We apply human-centered design to a variety of immunization challenges.Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Living Labs Initiative Overview
PATH’s Living Labs Initiative accelerates the pace of health innovation by co-creating with users to rapidly design, test, and scale solutions to their long-standing challenges. We apply human-centered design to a variety of immunization challenges.Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.COVID-19 Vaccine Label: User Evaluation
In order to unify the labeling requirements for COVID-19 vaccines that will be supplied through the Access to COVID-19 Tools (Act) Accelerator, draft models for the vial labels and packaging have been proposed by the World Health Organization and Coalition for Epidemic Preparedness Innovation (CEPI). PATH's Living Labs Initiative used...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.COVID-19 Vaccine Label: User Evaluation
In order to unify the labeling requirements for COVID-19 vaccines that will be supplied through the Access to COVID-19 Tools (Act) Accelerator, draft models for the vial labels and packaging have been proposed by the World Health Organization and Coalition for Epidemic Preparedness Innovation (CEPI). PATH's Living Labs Initiative used human-centered design methods to engage healthcare workers in Kenya and Zambia to evaluate these draft models. Their feedback on their desired features of vaccine labels and packaging have informed a series of recommendations for manufacturers for future vaccine vial development and for universal training guidelines for immunizations workers on the COVID-19 vaccine.
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Dan Brigden a réagi à cette publication il y a 5 ansJoin us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review)
Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00)The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design…
Lire la suiteJoin us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review)
Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00)The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design better data use interventions.
During this webinar, the presenters from PATH will share the methodology used to identify and review 549 pieces of evidence and five proven strategies to improve data use that were uncovered. They also will discuss the evidence gap map that was developed and how the global immunization community can work together to increase the quality of evidence available on best practices for data use to help further the work started by the IDEA team.
Discussion panelists
Laurie Werner- Director of Program, Center of Digital and Data Excellence, PATH
Allison Osterman- Program Officer, Health Systems Innovation and Delivery, PATH
Save the date and please join us!Link to register: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=ec0039a66d95132ed3f30c6988ade4314
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.M. Carolina Danovaro a réagi à cette publication il y a 5 ansJoin us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review)
Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00)The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design…
Lire la suiteJoin us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review)
Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00)The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design better data use interventions.
During this webinar, the presenters from PATH will share the methodology used to identify and review 549 pieces of evidence and five proven strategies to improve data use that were uncovered. They also will discuss the evidence gap map that was developed and how the global immunization community can work together to increase the quality of evidence available on best practices for data use to help further the work started by the IDEA team.
Discussion panelists
Laurie Werner- Director of Program, Center of Digital and Data Excellence, PATH
Allison Osterman- Program Officer, Health Systems Innovation and Delivery, PATH
Save the date and please join us!Link to register: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=ec0039a66d95132ed3f30c6988ade4314
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Dan Brigden a réagi à cette publication il y a 5 ansThe Immunization Data: Evidence for Action (IDEA) report and supporting materials are now available on the TechNet-21 website in English, Spanish and French.
The IDEA report, A Realist Review of What Works to Improve Data Use for Immunization: Evidence from low-and middle-income countries, was written by PATH and the Pan American Health Organization (PAHO). It provides the immunization community with clear, proven strategies for improving the quality and use of immunization data. In addition, it outlines how funders, policymakers, and program implementers can incorporate these best practices to improve the efficacy of state, regional, and national immunization programs.
The available materials include the full report, an executive summary, the review’s guiding Theory of Change, an evidence synthesis table and a summary of the five top findings.
In addition, there is an Evidence Gap Map. For each primary intervention type identified in the IDEA literature review, the gap map…
Lire la suiteThe Immunization Data: Evidence for Action (IDEA) report and supporting materials are now available on the TechNet-21 website in English, Spanish and French.
The IDEA report, A Realist Review of What Works to Improve Data Use for Immunization: Evidence from low-and middle-income countries, was written by PATH and the Pan American Health Organization (PAHO). It provides the immunization community with clear, proven strategies for improving the quality and use of immunization data. In addition, it outlines how funders, policymakers, and program implementers can incorporate these best practices to improve the efficacy of state, regional, and national immunization programs.
The available materials include the full report, an executive summary, the review’s guiding Theory of Change, an evidence synthesis table and a summary of the five top findings.
In addition, there is an Evidence Gap Map. For each primary intervention type identified in the IDEA literature review, the gap map visualizes all the pieces of evidence and promising strategies identified. The gap map illustrates where there is greater coverage of evidence and promising strategies as well as where there are gaps in evidence to help inform future research needs.
To view the Evidence Gap Map and all the IDEA materials please visit: https://www.technet-21.org/en/topics/idea
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Datos de Inmunización: Evidencia para la Acción (IDEA): Principales hallazgos de IDEA para los formuladores de políticas
Para mejorar los resultados de la inmunización es esencial contar con datos oportunos y de alta calidad. La revisión de IDEA es una síntesis global de la evidencia existente que ayuda a construir un entendimiento común de lo que funciona para mejorar la calidad y el uso de los datos de inmunización, por qué funciona y dónde se necesita más...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Données de vaccination : des preuves pour l’action (IDEA):Principaux résultats d’IDEA à l’intention des décideurs politiques
Les données de qualité, en temps utile, sont essentielles à l’amélioration des résultats de la vaccination. L’étude IDEA offre une synthèse globale des données probantes existantes, qui aide à produire une entente commune de « ce qui marche » pour améliorer la qualité et l’utilisation des données de vaccination, pourquoi et où...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.Aucune activité